Characterization of Infections With Extended-Spectrum β-Lactamase Producing<i>Escherichia coli</i>and<i>Klebsiella</i>Species at a Major Military Medical Center

Michael Koren(Walter Reed Army Institute of Research), Christina Schofield(Madigan Army Medical Center), Clinton K. Murray(Joint Commission), Samandra T. Demons(Madigan Army Medical Center), Steven D. Mahlen(Madigan Army Medical Center)
Military Medicine
June 27, 2014
10.7205/milmed-d-13-00473
Cited by 3

Related Papers

Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
|The Lancet|2017|196
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
|Gastroenterology|2021|177
Infection-Associated Clinical Outcomes in Hospitalized Medical Evacuees After Traumatic Injury: Trauma Infectious Disease Outcome Study
|The Journal of Trauma: Injury, Infection, and Critical Care|2011|137